NaV1.5 and regulatory β subunits in cardiac sodium channelopathies

Cardiac Electrophysiology Clinics

Volumn 6, Issue 4, 2014, Pages 679-694

  Bao, Yangyang ^a   Isom, Lori L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Animal model; Arrhythmia; Voltage gated sodium channel; Subunit

Indexed keywords

SODIUM CHANNEL NAV1.5; VOLTAGE GATED SODIUM CHANNEL BETA 1 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BETA 2 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BETA 3 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BETA 4 SUBUNIT; VOLTAGE GATED SODIUM CHANNEL BETA SUBUNIT;

CARDIAC CHANNELOPATHY; CELLULAR DISTRIBUTION; GENE MUTATION; HEART ATRIUM ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MACROMOLECULE; MUTATOR GENE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCN1B GENE; SCN2B GENE; SCN3B GENE; SCN4B GENE; TISSUE DISTRIBUTION;

EID: 84909980909     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2014.07.002     Document Type: Review

References (127)

1. Veeraraghavan R., Gourdie R., Poelzing S. Mechanisms of cardiac conduction: a history of revisions. Am J Physiol Heart Circ Physiol 2014, 306:H619-H627. 10.1152/ajpheart.00760.2013.
2. Catterall W.A. Voltage-gated sodium channels at 60: structure, function and pathophysiology. JPhysiol 2012, 590(Pt 11):2577-2589. 10.1113/jphysiol.2011.224204.
3. Morgan K., Stevens E.B., Shah B., et al. β3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating withdistinct kinetics. Proc Natl Acad Sci U S A 2000, 97(5):2308-2313. 10.1073/pnas.030362197.
4. Kazen-Gillespie K.A., Ragsdale D.S., D'Andrea M.R., et al. Cloning, localization, and functional expression of sodium channel β1A subunits. JBiol Chem 2000, 275(2):1079-1088. 10.1074/jbc.275.2.1079.
5. Yu F.H., Westenbroek R.E., Silos-Santiago I., et al. Sodium channel β4, a new disulfide-linked auxiliary subunit with similarity to β2. JNeurosci 2003, 23(20):7577-7585. Available at:. http://www.jneurosci.org/content/23/20/7577.abstract.
6. Isom L.L., De Jongh K.S., Patton D.E., et al. Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science 1992, 256(5058):839-842. Available at:, Accessed February 23, 2014. http://www.jstor.org/stable/2877043.
7. Isom L.L., Ragsdale D.S., De Jongh K.S., et al. Structure and function of the β2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 1995, 83(3):433-442. 10.1016/0092-8674(95)90121-3.
8. Isom L.L. The role of sodium channels in cell adhesion. Front Biosci 2002, 7:12-23.
9. Brackenbury W.J., Isom L.L. Na channel β subunits: overachievers of the ion channel family. Front Pharmacol 2011, 2:53. 10.3389/fphar.2011.00053.
10. Malhotra J.D., Thyagarajan V., Chen C., et al. Tyrosine-phosphorylated and nonphosphorylated sodium channel beta1 subunits are differentially localized in cardiac myocytes. JBiol Chem 2004, 279(39):40748-40754. 10.1074/jbc.M407243200.
11. Patino G.A., Brackenbury W.J., Bao Y., et al. Voltage-gated Na+ channel β1B: a secreted cell adhesion molecule involved in human epilepsy. JNeurosci 2011, 31(41):14577-14591. 10.1523/jneurosci.0361-11.2011.
12. Chen C., Calhoun J.D., Zhang Y., et al. Identification of the cysteine residue responsible for disulfide linkage of Na+ channel α and β2 subunits. JBiol Chem 2012, 287(46):39061-39069. 10.1074/jbc.M112.397646.
13. Rosati B., Pan Z., Lypen S., et al. Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle. JPhysiol 2001, 533(Pt 1):119-125. Available at:, Accessed February 27, 2014. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2278594%26tool=pmcentrez%26rendertype=abstract.
14. Dixon J.E., McKinnon D. Quantitative analysis of potassium channel mRNA expression in atrial and ventricular muscle of rats. Circ Res 1994, 75(2):252-260. Available at:, Accessed February 27, 2014. http://www.ncbi.nlm.nih.gov/pubmed/8033339.
15. Maier S.K., Westenbroek R.E., Yamanushi T.T., et al. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci U S A 2003, 100(6):3507-3512. 10.1073/pnas.2627986100.
16. Lei M., Jones S.A., Liu J., et al. Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking. JPhysiol 2004, 559(3):835-848. 10.1113/jphysiol.2004.068643.
17. Lei M., Goddard C., Liu J., et al. Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a. JPhysiol 2005, 567(2):387-400. 10.1113/jphysiol.2005.083188.
18. Marionneau C., Couette B., Liu J., et al. Specific pattern of ionic channel gene expression associated with pacemaker activity in the mouse heart. JPhysiol 2005, 562(Pt 1):223-234. 10.1113/jphysiol.2004.074047.
19. Gaborit N., Le Bouter S., Szuts V., et al. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. JPhysiol 2007, 582(Pt 2):675-693. 10.1113/jphysiol.2006.126714.
20. Fahmi A.I., Patel M., Stevens E.B., et al. The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart. JPhysiol 2001, 537(Pt 3):693-700. Available at:, Accessed February 20, 2014. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2278985%26tool=pmcentrez%26rendertype=abstract.
21. Dominguez J.N., Navarro F., Franco D., et al. Temporal and spatial expression pattern of beta1 sodium channel subunit during heart development. Cardiovasc Res 2005, 65(4):842-850. 10.1016/j.cardiores.2004.11.028.
22. Malhotra J.D., Chen C., Rivolta I., et al. Characterization of sodium channel α- and β-subunits in rat and mouse cardiac myocytes. Circulation 2001, 103(9):1303-1310. 10.1161/01.cir.103.9.1303.
23. Maier S.K., Westenbroek R.E., McCormick K.A., et al. Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart. Circulation 2004, 109(11):1421-1427. 10.1161/01.CIR.0000121421.61896.24.
24. Westenbroek R.E., Bischoff S., Fu Y., et al. Localization of sodium channel subtypes in mouse ventricular myocytes using quantitative immunocytochemistry. JMol Cell Cardiol 2013, 64:69-78. 10.1016/j.yjmcc.2013.08.004.
25. Kaufmann S.G., Westenbroek R.E., Maass A.H., et al. Distribution and function of sodium channel subtypes in human atrial myocardium. JMol Cell Cardiol 2013, 61:133-141. 10.1016/j.yjmcc.2013.05.006.
26. Hashemi S.M., Hund T.J., Mohler P.J. Cardiac ankyrins in health and disease. JMol Cell Cardiol 2009, 47(2):203-209. 10.1016/j.yjmcc.2009.04.010.
27. Lowe J.S., Palygin O., Bhasin N., et al. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway. JCell Biol 2008, 180(1):173-186. 10.1083/jcb.200710107.
28. Mohler P.J., Rivolta I., Napolitano C., et al. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A 2004, 101(50):17533-17538. 10.1073/pnas.0403711101.
29. Sato P.Y., Coombs W., Lin X., et al. Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc. Circ Res 2011, 109(2):193-201. 10.1161/CIRCRESAHA.111.247023.
30. Agullo-Pascual E., Cerrone M., Delmar M. Arrhythmogenic cardiomyopathy and Brugada syndrome: diseases of the connexome. FEBS Lett 2014, 10.1016/j.febslet.2014.02.008.
31. Mohler P.J., Schott J.J., Gramolini A.O., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003, 421(6923):634-639. 10.1038/nature01335.
32. Le Scouarnec S., Bhasin N., Vieyres C., et al. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease. Proc Natl Acad Sci U S A 2008, 105(40):15617-15622. 10.1073/pnas.0805500105.
33. Malhotra J.D., Koopmann M.C., Kazen-Gillespie K.A., et al. Structural requirements for interaction of sodium channel beta 1 subunits with ankyrin. JBiol Chem 2002, 277(29):26681-26688. 10.1074/jbc.M202354200.
34. Yang J.S., Bennett P.B., Makita N., et al. Expression of the sodium channel β1 subunit in rat skeletal muscle is selectively associated with the tetrodotoxin-sensitive α subunit isoform. Neuron 1993, 11(5):915-922. 10.1016/0896-6273(93)90121-7.
35. Makita N., Bennett P.B., George A.L. Voltage-gated Na+ channel beta 1 subunit mRNA expressed in adult human skeletal muscle, heart, and brain is encoded by a single gene. JBiol Chem 1994, 269(10):7571-7578. Available at:. http://www.jbc.org/content/269/10/7571.abstract.
36. Qu Y., Isom L.L., Westenbroek R.E., et al. Modulation of cardiac Na+ channel expression in Xenopus oocytes by β1 subunits. JBiol Chem 1995, 270(43):25696-25701. 10.1074/jbc.270.43.25696.
37. An R.H., Wang X.L., Kerem B., et al. Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunits. Circ Res 1998, 83(2):141-146. Available at:, Accessed February 23, 2014. http://www.ncbi.nlm.nih.gov/pubmed/9686753.
38. Ko S.H., Lenkowski P.W., Lee H.C., et al. Modulation of Na(v)1.5 by beta1- and beta3-subunit co-expression in mammalian cells. Pflugers Arch 2005, 449(4):403-412. 10.1007/s00424-004-1348-4.
39. Moran O., Nizzari M., Conti F. Endogenous expression of the β1A sodium channel subunit in HEK-293 cells. FEBS Lett 2000, 473(2):132-134. 10.1016/s0014-5793(00)01518-0.
40. Moran O., Conti F., Tammaro P. Sodium channel heterologous expression in mammalian cells and the role of the endogenous β1-subunits. Neurosci Lett 2003, 336(3):175-179. 10.1016/s0304-3940(02)01284-3.
41. Moran O., Tammaro P., Nizzari M., et al. Functional properties of sodium channels do not depend on the cytoskeleton integrity. Biochem Biophys Res Commun 2000, 276(1):204-209. 10.1006/bbrc.2000.3463.
42. Meadows L.S., Isom L.L. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc Res 2005, 67(3):448-458. 10.1016/j.cardiores.2005.04.003.
43. Watanabe H., Koopmann T.T., Le Scouarnec S., et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. JClin Invest 2008, 118(6):2260-2268. 10.1172/JCI33891.
44. Watanabe H., Darbar D., Kaiser D.W., et al. Mutations in sodium channel beta1- and beta2-subunits associated with atrial fibrillation. Circ Arrhythm Electrophysiol 2009, 2(3):268-275. 10.1161/CIRCEP.108.779181.
45. Grieco T.M., Malhotra J.D., Chen C., et al. Open-channel block by the cytoplasmic tail of sodium channel β4 as a mechanism for resurgent sodium current. Neuron 2005, 45(2):233-244. 10.1016/j.neuron.2004.12.035.
46. Brackenbury W.J., Calhoun J.D., Chen C., et al. Functional reciprocity between Na+ channel Nav1.6 and beta1 subunits in the coordinated regulation of excitability and neurite outgrowth. Proc Natl Acad Sci U S A 2010, 107(5):2283-2288. 10.1073/pnas.0909434107.
47. Wang G.K., Edrich T., Wang S.Y. Time-dependent block and resurgent tail currents induced by mouse β4154-167 peptide in cardiac Na+ channels. JGen Physiol 2006, 127(3):277-289. 10.1085/jgp.200509399.
48. Medeiros-Domingo A., Kaku T., Tester D.J., et al. SCN4B-encoded sodium channel β4 subunit in congenital long-QT syndrome. Circulation 2007, 116(2):134-142. 10.1161/circulationaha.106.659086.
49. Tan B.H., Pundi K.N., Van Norstrand D.W., et al. Sudden infant death syndrome-associated mutations in the sodium channel beta subunits. Heart Rhythm 2010, 7(6):771-778. 10.1016/j.hrthm.2010.01.032.
50. Valdivia C.R., Medeiros-Domingo A., Ye B., et al. Loss-of-function mutation of the SCN3B-encoded sodium channel β3 subunit associated with a case of idiopathic ventricular fibrillation. Cardiovasc Res 2010, 86(3):392-400. 10.1093/cvr/cvp417.
51. Patino G.A., Claes L.R., Lopez-Santiago L.F., et al. Afunctional null mutation of SCN1B in a patient with Dravet syndrome. JNeurosci 2009, 29(34):10764-10778. 10.1523/JNEUROSCI.2475-09.2009.
52. Ogiwara I., Nakayama T., Yamagata T., et al. Ahomozygous mutation of voltage-gated sodium channel β(I) gene SCN1B in a patient with Dravet syndrome. Epilepsia 2012, 53(12):e200-e203. 10.1111/epi.12040.
53. Chen C., Westenbroek R.E., Xu X., et al. Mice lacking sodium channel β1 subunits display defects in neuronal excitability, sodium channel expression, and nodalarchitecture. JNeurosci 2004, 24(16):4030-4042. 10.1523/jneurosci.4139-03.2004.
54. Lopez-Santiago L.F., Meadows L.S., Ernst S.J., et al. Sodium channel Scn1b null mice exhibit prolonged QTand RR intervals. JMol Cell Cardiol 2007, 43(5):636-647. 10.1016/j.yjmcc.2007.07.062.
55. Hu D., Barajas-Martínez H., Medeiros-Domingo A., et al. Anovel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Nav1.5 and Kv4.3 channel currents. Heart Rhythm 2012, 10.1016/j.hrthm.2011.12.006.
56. Li A., Behr E.R. Brugada syndrome: an update. Future Cardiol 2013, 9(2):253-271. 10.2217/fca.12.82.
57. Meregalli P.G., Wilde A.M., Tan H.L. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc Res 2005, 67(3):367-378. 10.1016/j.cardiores.2005.03.005.
58. Olesen M.S., Holst A.G., Svendsen J.H., et al. SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation. Heart Rhythm 2012, 9(5):770-773. 10.1016/j.hrthm.2011.12.005.
59. Holst A.G., Saber S., Houshmand M., et al. Sodium current and potassium transient outward current genes in Brugada syndrome: screening and bioinformatics. Can J Cardiol 2012, 10.1016/j.cjca.2011.11.011.
60. Liu C., Tester D.J., Hou Y., et al. Is sudden unexplained nocturnal death syndrome in southern China a cardiac sodium channel dysfunction disorder?. Forensic Sci Int 2014, 236C:38-45. 10.1016/j.forsciint.2013.12.033.
61. Vatta M., Dumaine R., Varghese G., et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002, 11(3):337-345. Available at:, Accessed February 18, 2014. http://www.ncbi.nlm.nih.gov/pubmed/11823453.
62. Ellinor P.T., Nam E.G., Shea M.A., et al. Cardiac sodium channel mutation in atrial fibrillation. Heart Rhythm 2008, 5(1):99-105. 10.1016/j.hrthm.2007.09.015.
63. Remme C.A. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects. JPhysiol 2013, 10.1113/jphysiol.2013.256461.
64. Scheffer I.E., Harkin L.A., Grinton B.E., et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007, 130(Pt 1):100-109. 10.1093/brain/awl272.
65. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002, 415(6868):219-226. 10.1038/415219a.
66. Brackenbury W.J., Yuan Y., O'Malley H.A., et al. Abnormal neuronal patterning occurs during early postnatal brain development of Scn1b-null mice and precedes hyperexcitability. Proc Natl Acad Sci U S A 2013, 110(3):1089-1094. 10.1073/pnas.1208767110.
67. Riuró H., Beltran-Alvarez P., Tarradas A., et al. Amissense mutation in the sodium channel β2 subunit reveals SCN2B as a new candidate gene for Brugada syndrome. Hum Mutat 2013, 34(7):961-966. 10.1002/humu.22328.
68. 1) and γ-secretase. JBiol Chem 2005, 280(24):23009-23017. 10.1074/jbc.M414648200.
69. Kim D.Y., Carey B.W., Wang H., et al. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 2007, 9(7):755-764. Available at:. http://www.nature.com/ncb/journal/v9/n7/suppinfo/ncb1602_S1.html.
70. Hu D., Barajas-Martinez H., Burashnikov E., et al. Amutation in the β3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype/clinical perspective. Circ Cardiovasc Genet 2009, 2(3):270-278. 10.1161/circgenetics.108.829192.
71. Ishikawa T., Takahashi N., Ohno S., et al. Novel SCN3B mutation associated with Brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J 2013, 77(4):959-967. 10.1253/circj.CJ-12-0995.
72. Kurakami K., Ishii K. Is a novel SCN3B mutation commonly found in SCN5A-negative Brugada syndrome patients?. Circ J 2013, 77(4):900-901. 10.1253/circj.CJ-13-0242.
73. Marcus F.I., Zareba W. The electrocardiogram in right ventricular cardiomyopathy/dysplasia. How can the electrocardiogram assist in understanding the pathologic and functional changes of the heart in this disease?. JElectrocardiol 2009, 42(2):136.e1-136.e5. 10.1016/j.jelectrocard.2008.12.011.
74. Cox M.G., van der Zwaag P.A., van der Werf C., et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study. Circulation 2011, 123(23):2690-2700. 10.1161/CIRCULATIONAHA.110.988287.
75. Marcus F.I., Zareba W., Calkins H., et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm 2009, 6(7):984-992. 10.1016/j.hrthm.2009.03.013.
76. Wang P., Yang Q., Wu X., et al. Functional dominant-negative mutation of sodium channel subunit gene SCN3B associated with atrial fibrillation in a Chinese GeneID population. Biochem Biophys Res Commun 2010, 398(1):98-104. 10.1016/j.bbrc.2010.06.042.
77. Olesen M.S., Jespersen T., Nielsen J.B., et al. Mutations in sodium channel β-subunit SCN3B are associated with early-onset lone atrial fibrillation. Cardiovasc Res 2011, 89(4):786-793. 10.1093/cvr/cvq348.
78. Hakim P., Gurung I.S., Pedersen T.H., et al. Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties. Prog Biophys Mol Biol 2008, 98(2-3):251-266. 10.1016/j.pbiomolbio.2009.01.005.
79. Hakim P., Brice N., Thresher R., et al. Scn3b knockout mice exhibit abnormal sino-atrial and cardiac conduction properties. Acta Physiol (Oxf) 2010, 198(1):47-59. 10.1111/j.1748-1716.2009.02048.x.
80. Namadurai S., Balasuriya D., Rajappa R., et al. Crystal structure and molecular imaging of the Nav channel β3 subunit indicates a trimeric assembly. JBiol Chem 2014, 10.1074/jbc.M113.527994.
81. McEwen D.P., Chen C., Meadows L.S., et al. The voltage-gated Na+ channel β3 subunit does not mediate trans homophilic cell adhesion or associate with the cell adhesion molecule contactin. Neurosci Lett 2009, 462(3):272-275. 10.1016/j.neulet.2009.07.020.
82. Yereddi N.R., Cusdin F.S., Namadurai S., et al. The immunoglobulin domain of the sodium channel β3 subunit contains a surface-localized disulfide bond that is required for homophilic binding. FASEB J 2013, 27(2):568-580. 10.1096/fj.12-209445.
83. Li R.G., Wang Q., Xu Y.J., et al. Mutations of the SCN4B-encoded sodium channel β4 subunit in familial atrial fibrillation. Int J Mol Med 2013, 32(1):144-150. 10.3892/ijmm.2013.1355.
84. Wang D.W., Yazawa K., George A.L., et al. Characterization of human cardiac Na+ channel mutations in the congenital long QT syndrome. Proc Natl Acad Sci U S A 1996, 93(23):13200-13205. Available at:, Accessed February 21, 2014. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24070%26tool=pmcentrez%26rendertype=abstract.
85. Yan G.X., Wu Y., Liu T., et al. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 2001, 103(23):2851-2856. Available at:, Accessed February 15, 2014. http://www.ncbi.nlm.nih.gov/pubmed/11401944.
86. Trippel D.L., Parsons M.K., Gillette P.C. Infants with long-QT syndrome and 2:1 atrioventricular block. Am Heart J 1995, 130(5):1130-1134. Available at:, Accessed February 21, 2014. http://www.ncbi.nlm.nih.gov/pubmed/7484750.
87. Gorgels A.P., Al Fadley F., Zaman L., et al. The long QT syndrome with impaired atrioventricular conduction: a malignant variant in infants. JCardiovasc Electrophysiol 1998, 9(11):1225-1232. Available at:, Accessed February 21, 2014. http://www.ncbi.nlm.nih.gov/pubmed/9835268.
88. Remme C.A., Scicluna B.P., Verkerk A.O., et al. Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ Res 2009, 104(11):1283-1292. 10.1161/circresaha.109.194423.
89. Gilchrist J., Das S., Van Petegem F., et al. Crystallographic insights into sodium-channel modulation by the β4 subunit. Proc Natl Acad Sci U S A 2013, 110(51):E5016-E5024. 10.1073/pnas.1314557110.
90. Møller D.V., Andersen P.S., Hedley P., et al. The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet 2009, 17(10):1241-1249. 10.1038/ejhg.2009.34.
91. Makita N., Shirai N., Wang D.W., et al. Cardiac Na+ channel dysfunction in Brugada syndrome is aggravated by 1-subunit. Circulation 2000, 101(1):54-60. 10.1161/01.CIR.101.1.54.
92. Mercier A., Clément R., Harnois T., et al. The β1-subunit of Na(v)1.5 cardiac sodium channel is required for a dominant negative effect through α-α interaction. PLoS One 2012, 7(11):e48690. 10.1371/journal.pone.0048690.
93. Deschênes I., Armoundas A.A., Jones S.P., et al. Post-transcriptional gene silencing of KChIP2 and Navbeta1 in neonatal rat cardiac myocytes reveals a functional association between Na and Ito currents. JMol Cell Cardiol 2008, 45(3):336-346. 10.1016/j.yjmcc.2008.05.001.
94. Du Y., Huang X., Wang T., et al. Downregulation of neuronal sodium channel subunits Nav1.1 and Nav1.6 in the sinoatrial node from volume-overloaded heart failure rat. Pflugers Arch 2007, 454(3):451-459. 10.1007/s00424-007-0216-4.
95. Maier S.K., Westenbroek R.E., Schenkman K.A., et al. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc Natl Acad Sci U S A 2002, 99(6):4073-4078. 10.1073/pnas.261705699.
96. Torres N.S., Larbig R., Rock A., et al. Na+ currents are required for efficient excitation-contraction coupling in rabbit ventricular myocytes: a possible contribution of neuronal Na+ channels. JPhysiol 2010, 588(Pt 21):4249-4260. 10.1113/jphysiol.2010.194688.
97. Noujaim S.F., Kaur K., Milstein M., et al. Anull mutation of the neuronal sodium channel NaV1.6 disrupts action potential propagation and excitation-contraction coupling in the mouse heart. FASEB J 2012, 26(1):63-72. 10.1096/fj.10-179770.
98. Lin X., O'Malley H., Chen C., et al. Scn1b deletion leads to increased tetrodotoxin-sensitive sodium current, altered intracellular calcium homeostasis, and arrhythmias in murine hearts. J Physiol 2014, [Epub ahead of print].
99. Aman T.K., Grieco-Calub T.M., Chen C., et al. Regulation of persistent Na current by interactions between β subunits of voltage-gated Na channels. JNeurosci 2009, 29(7):2027-2042. 10.1523/jneurosci.4531-08.2009.
100. Lopez-Santiago L.F., Brackenbury W.J., Chen C., et al. Na+ channel Scn1b gene regulates dorsal root ganglion nociceptor excitability invivo. JBiol Chem 2011, 286(26):22913-22923. 10.1074/jbc.M111.242370.
101. Chen C., Bharucha V., Chen Y., et al. Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A 2002, 99(26):17072-17077. 10.1073/pnas.212638099.
102. Lopez-Santiago L.F., Pertin M., Morisod X., et al. Sodium channel β2 subunits regulate tetrodotoxin-sensitive sodium channels in small dorsal root ganglion neurons and modulate the response to pain. JNeurosci 2006, 26(30):7984-7994. 10.1523/jneurosci.2211-06.2006.
103. Chambers J.C., Zhao J., Terracciano C.M., et al. Genetic variation in SCN10A influences cardiac conduction. Nat Genet 2010, 42(2):149-152. 10.1038/ng.516.
104. Zhao J., O'Leary M.E., Chahine M. Regulation of Nav1.6 and Nav1.8 peripheral nerve Na+ channels by auxiliary β-subunits. JNeurophysiol 2011, 106(2):608-619. 10.1152/jn.00107.2011.
105. Verkerk A.O., Remme C.A., Schumacher C.A., et al. Functional Nav1.8 channels in intracardiac neurons: the link between SCN10A and cardiac electrophysiology. Circ Res 2012, 111(3):333-343. 10.1161/CIRCRESAHA.112.274035.
106. Vijayaragavan K., Powell A.J., Kinghorn I.J., et al. Role of auxiliary beta1-, beta2-, and beta3-subunits and their interaction with Na(v)1.8 voltage-gated sodium channel. Biochem Biophys Res Commun 2004, 319(2):531-540. 10.1016/j.bbrc.2004.05.026.
107. Deschênes I., Tomaselli G.F. Modulation of Kv4.3 current by accessory subunits. FEBS Lett 2002, 528(1-3):183-188. Available at:. http://www.ncbi.nlm.nih.gov/pubmed/12297301.
108. Marionneau C., Carrasquillo Y., Norris A.J., et al. The sodium channel accessory subunit Navβ1 regulates neuronal excitability through modulation of repolarizing voltage-gated K+ channels. JNeurosci 2012, 32(17):5716-5727. 10.1523/jneurosci.6450-11.2012.
109. Nerbonne J.M., Kass R.S. Molecular physiology of cardiac repolarization. Physiol Rev 2005, 85(4):1205-1253. 10.1152/physrev.00002.2005.
110. Makielski J.C., Limberis J.T., Chang S.Y., et al. Coexpression of beta 1 with cardiac sodium channel alpha subunits in oocytes decreases lidocaine block. Mol Pharmacol 1996, 49(1):30-39. Available at:, Accessed February 9, 2014. http://www.ncbi.nlm.nih.gov/pubmed/8569709.
111. Brugada R., Brugada J., Antzelevitch C., et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000, 101(5):510-515. Available at:, Accessed February 19, 2014. http://www.ncbi.nlm.nih.gov/pubmed/10662748.
112. Windle J.R., Geletka R.C., Moss A.J., et al. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A: DeltaKPQ mutation. Ann Noninvasive Electrocardiol 2001, 6(2):153-158. Available at:, Accessed February 19, 2014. http://www.ncbi.nlm.nih.gov/pubmed/11333173.
113. Belhassen B., Glick A., Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004, 110(13):1731-1737. 10.1161/01.CIR.0000143159.30585.90.
114. Zipes D.P., Camm A.J., Borggrefe M., et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006, 114:e385-e484. 10.1161/CIRCULATIONAHA.106.178233.
115. Stokoe K.S., Balasubramaniam R., Goddard C.A., et al. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/- murine hearts modelling the Brugada syndrome. JPhysiol 2007, 581(Pt1):255-275. 10.1113/jphysiol.2007.128785.
116. Hakim P., Thresher R., Grace A.A., et al. Effects of flecainide and quinidine on action potential and ventricular arrhythmogenic properties in Scn3b knockout mice. Clin Exp Pharmacol Physiol 2010, 37(8):782-789. 10.1111/j.1440-1681.2010.05369.x.
117. Uebachs M., Albus C., Opitz T., et al. Loss of β1 accessory Na+ channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high-frequency firing via differential effects on persistent Na+ currents. Epilepsia 2012, 53(11):1959-1967. 10.1111/j.1528-1167.2012.03675.x.
118. Undrovinas A.I., Belardinelli L., Undrovinas N.A., et al. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. JCardiovasc Electrophysiol 2006, 17(Suppl 1):S169-S177. 10.1111/j.1540-8167.2006.00401.x.
119. Mishra S., Undrovinas N.A., Maltsev V.A., et al. Post-transcriptional silencing of SCN1B and SCN2B genes modulates late sodium current in cardiac myocytes from normal dogs and dogs with chronic heart failure. Am J Physiol Heart Circ Physiol 2011, 301(4):H1596-H1605. 10.1152/ajpheart.00948.2009.
120. Viswanathan P.C., Benson D.W., Balser J.R. Acommon SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. JClin Invest 2003, 111(3):341-346. 10.1172/JCI16879.
121. Ye B., Valdivia C.R., Ackerman M.J., et al. Acommon human SCN5A polymorphism modifies expression of an arrhythmia causing mutation. Physiol Genomics 2003, 12(3):187-193. 10.1152/physiolgenomics.00117.2002.
122. Schwartz P.J., Priori S.G., Napolitano C. How really rare are rare diseases?: The intriguing case of independent compound mutations in the long QT syndrome. JCardiovasc Electrophysiol 2003, 14(10):1120-1121. Available at:, Accessed February 21, 2014. http://www.ncbi.nlm.nih.gov/pubmed/14521668.
123. Olesen M.S., Nielsen M.W., Haunsø S., et al. Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet 2014, 22(3):297-306. 10.1038/ejhg.2013.139.
124. Moretti A., Laugwitz K.L., Dorn T., et al. Pluripotent stem cell models of human heart disease. Cold Spring Harb Perspect Med 2013, 5(11). 10.1101/cshperspect.a014027.
125. Sarić T., Halbach M., Khalil M., et al. Induced pluripotent stem cells as cardiac arrhythmic invitro models and the impact for drug discovery. Expert Opin Drug Discov 2014, 9(1):55-76. 10.1517/17460441.2014.863275.
126. Shy D., Gillet L., Abriel H. Cardiac sodium channel Na(V)1.5 distribution in myocytes via interacting proteins: the multiple pool model. Biochim Biophys Acta 2012, 10.1016/j.bbamcr.2012.10.026.
127. Yuan L., Koivumaki J., Liang B., et al. Investigations of the Navβ1b sodium channel subunit in human ventricle functional characterization of the H162P Brugada syndrome mutant. Am J Physiol Heart Circ Physiol 2014, 10.1152/ajpheart.00405.2013.